Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-25-029914

President/CEO acquired 6,725 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gilad Oren President/CEO 2025-03-27 Grant or award +6,725 340,120 D
Derivatives
Gilad Oren President/CEO 2025-03-27 Grant or award · Stock Options (Right to Buy) +26,900 26,900 D
Loading xslF345X05/tm2510809-1_4seq1.xml…